Hepatitis B hos børn

Vibeke Brix Christensen; Sannie Brit Nordly; Mette Kjær; Marianne Hørby Jørgensen

Hepatitis B hos børn

Translated title of the contribution: Hepatitis B infection in children.

Vibeke Brix Christensen, Sannie Brit Nordly, Mette Kjær, Marianne Hørby Jørgensen

Abstract

Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

Translated title of the contribution	Hepatitis B infection in children.
Original language	Danish
Article number	V02130135
Journal	Ugeskrift for Laeger
Volume	176
Issue number	8
Pages (from-to)	726-729
Number of pages	4
ISSN	0041-5782
Publication status	Published - 14 Apr 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{0eb357f7dc2c43cebfd540f26dab9046,

title = "Hepatitis B hos b{\o}rn",

abstract = "Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.",

author = "Christensen, {Vibeke Brix} and Nordly, {Sannie Brit} and Mette Kj{\ae}r and J{\o}rgensen, {Marianne H{\o}rby}",

year = "2014",

month = apr,

day = "14",

language = "Dansk",

volume = "176",

pages = "726--729",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "8",

}

TY - JOUR

T1 - Hepatitis B hos børn

AU - Christensen, Vibeke Brix

AU - Nordly, Sannie Brit

AU - Kjær, Mette

AU - Jørgensen, Marianne Hørby

PY - 2014/4/14

Y1 - 2014/4/14

N2 - Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

AB - Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

M3 - Tidsskriftartikel

C2 - 25096461

SN - 0041-5782

VL - 176

SP - 726

EP - 729

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 8

M1 - V02130135

ER -

Hepatitis B hos børn

Abstract

UN SDGs

Fingerprint

Cite this